First Human Application of 'Ląstelių Perprogramavimo' Injection

Boston-based biotechnology company Life Biosciences announced that a patient has been administered the 'ląstelių perprogramavimo' injection for the…

The purpose of this injection is to treat eye diseases without requiring surgery.